Guardant Health Secures FDA Nod for HER2-Mutant NSCLC Diagnostic
PALO ALTO, Calif., June 11, 2026 Guardant Health announced that the U.S. Food and Drug Administration (FDA) has approved...
companion diagnostic
Advertisement
Merck Animal Health Acquires TARGAN to Advance Poultry Technology
RAHWAY, N.J., June 11, 2026 Merck Animal Health, a division of Merck & Co., Inc., has signed a definitive...
Roche Expands VENTANA MMR Companion Diagnostic Across Multiple Cancer Types
TUCSON, Arizona, USA, June 11, 2026 Roche Diagnostics has announced a significant expansion of its precision oncology diagnostics portfolio...
Foundation Medicine Gains FDA Approval for TALZENNA CDx
BOSTON, June 1, 2026 Foundation Medicine announced that the U.S. Food and Drug Administration (FDA) has approved both FoundationOne®...
Foundation Medicine Wins FDA Approval for FoundationOne CDx in NSCLC
Boston, Massachusetts, USA, May 21, 2026 Foundation Medicine has announced that the U.S. Food and Drug Administration (FDA) has...
Advertisements
Guardant Health Gains FDA Nod for Breast Cancer CDx
PALO ALTO, Calif., May 4, 2026 Guardant Health, Inc. has received U.S. Food and Drug Administration (FDA) approval for...
Labcorp Enables KEYTRUDA Access with FDA Diagnostic
BURLINGTON, N.C., April 22, 2026 Labcorp announced the nationwide availability of the FDA-approved PD-L1 IHC 22C3 pharmDx companion diagnostic,...
Agilent Wins FDA Approval for PD-L1 22C3 Test
Santa Clara, USA – March 26, 2026 Agilent Technologies announced U.S. FDA approval of its PD-L1 IHC 22C3 pharmDx...
Myriad CDx Test Approved to Guide Ovarian Cancer Therapy
SALT LAKE CITY, March 17, 2026 Myriad Genetics, Inc. announced that the U.S. Food and Drug Administration (FDA) has...
Advertisement
